TuHURA Biosciences, Inc./NV
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
NV
Business Address
10500 UNIVERSITY CENTER DR., TAMPA, FL, 33612
Mailing Address
10500 UNIVERSITY CENTER DR., TAMPA, FL, 33612
Phone
813-875-6600
Fiscal Year End
1231
EIN
990360497
Financial Overview
FY2025
$6.42M
Total Liabilities
$-0.63
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | April 1, 2026 | View on SEC |
| 10-K Annual financial report | March 31, 2026 | View on SEC |
| 4 Insider stock transaction report | February 17, 2026 | View on SEC |
| 4 Insider stock transaction report | February 17, 2026 | View on SEC |
| 4 Insider stock transaction report | February 17, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 17, 2026 | View on SEC |
| 4 Insider stock transaction report | February 17, 2026 | View on SEC |
| 4 Insider stock transaction report | February 17, 2026 | View on SEC |
| 8-K Current report of material events | January 30, 2026 | View on SEC |
| 4 Insider stock transaction report | January 8, 2026 | View on SEC |
Annual Reports
10-K
March 31, 2026
- Advanced immuno-oncology pipeline featuring lead product IFx-2.0 for 'cold' tumor conversion.
- Strategic merger with Kineta, Inc. expanded research capabilities with VISTA & DOR technology.
Material Events
8-K
Financial Distress
January 30, 2026
High Impact
- Notice does not immediately affect the Company’s business, operations, or reporting requirements.
- Notice has no immediate effect on business operations or financial condition.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.